Cargando…
Evaluation of rs10811661 polymorphism in CDKN2A / B in colon and gastric cancer
One of the causes of colon and gastric cancer is the dysregulation of carcinogenic genes, tumor inhibitors, and micro-RNA. The purpose of this study is to apply rs10811661 polymorphism in CDKN2A /B gene as an effective biomarker of colon cancer and early detection of gastric cancer. As a result,400...
Autores principales: | Beihaghi, Maria, Sahebi, Reza, Beihaghi, Mohammad Reza, Nessiani, Raheleh Khosravi, Yarasmi, Majedeh Ramian, Gholamalizadeh, Sajad, Shahabnavaie, Fatemeh, shojaei, Mitra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577985/ https://www.ncbi.nlm.nih.gov/pubmed/37845622 http://dx.doi.org/10.1186/s12885-023-11461-6 |
Ejemplares similares
-
Variants of CDKAL1 rs7754840 (G/C) and CDKN2A/2B rs10811661 (C/T) with gestational diabetes: insignificant association
por: Noury, Amr El, et al.
Publicado: (2018) -
CDKN2A-rs10811661 polymorphism, waist-hip ratio, systolic blood pressure, and dyslipidemia are the independent risk factors for prediabetes in a Vietnamese population
por: Binh, Tran Quang, et al.
Publicado: (2015) -
Transient expression of CCL21as recombinant protein in tomato
por: Beihaghi, Maria, et al.
Publicado: (2017) -
Association of RB1 rs9568036 and CDKN1A rs1801270 Polymorphisms with Retinoblastoma Susceptibility
por: Azimi, Fatemeh, et al.
Publicado: (2022) -
In silico analysis and in planta production of recombinant ccl21/IL1β protein and characterization of its in vitro anti-tumor and immunogenic activity
por: Marashi, Hasan, et al.
Publicado: (2022)